vimarsana.com

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report)’s stock price gapped up prior to trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $8.00 to $9.00. The stock had previously closed at $8.86, but opened at $10.24. JPMorgan Chase & Co. currently has a neutral rating on the […]

Related Keywords

Ohio ,United States , ,Voloridge Investment Management ,Jpmorgan Chase Co ,Barclays Plc ,Editas Medicine Company Profile ,Virtu Financial ,Editas Medicine Inc ,Gotham Asset Management ,Nasdaq ,Editas Medicine ,Get Free Report ,Employees Retirement System ,Investment Management ,Leber Congenital Amaurosis ,Editas Medicine Daily ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.